pravastatin has been researched along with cholecalciferol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Inui, K; Nakano, T; Nanba, E; Ohno, K; Okada, S; Takeshita, K | 1 |
| Fujii, T; Fujii, Y; Ito, M; Machida, K; Ochiai, A | 1 |
| Atanassova, P; Bełtowski, J; Chaldakov, GN; Jamroz-Wiśniewska, A; Kula, W; Rusek, M | 1 |
| Hayashi, K; Ikushiro, S; Kamakura, M; Ohta, M; Sakaki, T; Shiro, Y; Sugimoto, H; Takita, T; Yasuda, K; Yasukawa, K | 1 |
1 review(s) available for pravastatin and cholecalciferol
| Article | Year |
|---|---|
Protein engineering of CYP105s for their industrial uses.
Topics: Actinobacteria; Amino Acid Substitution; Bacterial Proteins; Cholecalciferol; Conserved Sequence; Cytochrome P-450 Enzyme System; Ferredoxins; Gene Expression; Hydroxylation; Isoenzymes; Lovastatin; Molecular Docking Simulation; Mutation; Pravastatin; Protein Engineering; Streptomyces; Substrate Specificity | 2018 |
4 other study(ies) available for pravastatin and cholecalciferol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Altered sensitivities to potential inhibitors of cholesterol biosynthesis in Niemann-Pick type C fibroblasts.
Topics: Acetates; Adult; Amphotericin B; Anticholesteremic Agents; Cell Survival; Cells, Cultured; Cerulenin; Child; Cholecalciferol; Cholesterol; Cholesterol Esters; Fibroblasts; Filipin; Humans; Japan; Lipids; Male; Niemann-Pick Diseases; Pravastatin | 1993 |
Efficient biotransformations using Escherichia coli with tolC acrAB mutations expressing cytochrome P450 genes.
Topics: Bacterial Outer Membrane Proteins; Calcifediol; Cholecalciferol; Cholestenones; Cytochrome P-450 Enzyme System; Escherichia coli; Escherichia coli Proteins; Hydrophobic and Hydrophilic Interactions; Intracellular Space; Lovastatin; Membrane Transport Proteins; Mutation; Oxidation-Reduction; Pravastatin; Spectrum Analysis; Stereoisomerism; Substrate Specificity | 2009 |
Opposite effects of pravastatin and atorvastatin on insulin sensitivity in the rat: role of vitamin D metabolites.
Topics: Adipokines; Adipose Tissue; Animals; Atorvastatin; Biomarkers; Blood Glucose; Calcifediol; Calcitriol; Cholecalciferol; Fasting; Fatty Acids, Nonesterified; Glucose Clamp Technique; Glycerol; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Insulin; Insulin Resistance; Liver; Male; Muscle, Skeletal; Pravastatin; Pyrroles; Rats; Rats, Wistar; Time Factors | 2011 |